| 16.13 Delayed Data As of Oct 18 |  -0.26 / -1.59%Today’s Change | 11.78 Today|||52-Week Range 23.91 | +18.52% Year-to-Date |
| Why Amarin Investors Have Their Eyes on Nov. 14 Oct 13 / MotleyFool.com - Paid Partner Content | Will The Pace of M&A Pick Up Following The Biotech Sector’s Pounding? Oct 11 / MotleyFool.com - Paid Partner Content |
| Previous close | 16.39 |
| Today’s open | 16.39 |
| Day’s range | 16.02 - 16.52 |
| Volume | 3,615,230 |
| Average volume (3 months) | 7,961,402 |
| Market cap | $5.8B |
| Earnings growth (last year) | -54.77% |
| Earnings growth (this year) | +42.82% |
| Earnings growth (next 5 years) | +35.40% |
| Revenue growth (last year) | +25.01% |
| P/E ratio | NM |
| Price/Sales | 17.68 |
| Price/Book | 40.31 |
| Today’s change | Today’s % change | |
|---|---|---|
| SYNHSyneos Health Inc | -0.34 | -0.61% |
| PRAHPRA Health Sciences ... | -0.51 | -0.52% |
| EXELExelixis Inc | -0.58 | -3.41% |
| CRLCharles River Labora... | -1.79 | -1.32% |
| Next reporting date | October 31, 2019 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $228.8M |
| Annual profit (last year) | -$116.2M |
| Net profit margin | -50.80% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Dublin, Dublin |
